| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.01B | 90.09B | 82.88B | 76.89B | 77.96B | 66.85B |
| Gross Profit | 15.73B | 17.82B | 19.88B | 15.46B | 18.53B | 16.09B |
| EBITDA | 7.90B | 9.18B | 8.22B | 5.63B | 8.57B | 7.99B |
| Net Income | 820.00M | 3.89B | 2.23B | 1.51B | 3.15B | 4.66B |
Balance Sheet | ||||||
| Total Assets | 77.57B | 89.36B | 76.28B | 76.41B | 70.66B | 66.87B |
| Cash, Cash Equivalents and Short-Term Investments | 17.23B | 18.17B | 17.12B | 18.70B | 17.69B | 13.82B |
| Total Debt | 10.22B | 11.65B | 10.51B | 13.59B | 11.18B | 7.77B |
| Total Liabilities | 26.15B | 29.01B | 24.25B | 26.02B | 23.43B | 22.54B |
| Stockholders Equity | 51.33B | 60.23B | 51.94B | 50.30B | 47.16B | 44.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.11B | 4.76B | 906.00M | 2.67B | -1.06B |
| Operating Cash Flow | 0.00 | 4.32B | 7.24B | 4.82B | 7.31B | 3.68B |
| Investing Cash Flow | 0.00 | -4.42B | -4.08B | -5.13B | -5.86B | -5.97B |
| Financing Cash Flow | 0.00 | -174.00M | -4.62B | -260.00M | 1.53B | 171.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥770.32B | 20.33 | 8.07% | 2.85% | 11.53% | 1.60% | |
77 Outperform | ¥11.37T | 20.30 | 8.95% | 1.88% | 5.02% | 2.02% | |
74 Outperform | ¥5.58T | 64.56 | ― | 1.41% | 13.61% | 17.01% | |
71 Outperform | ¥112.82B | 17.71 | ― | 2.20% | 8.69% | 74.50% | |
66 Neutral | ¥421.46B | 15.45 | 11.96% | 3.04% | 2.93% | -26.76% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥171.66B | 15.01 | 5.91% | 2.39% | 2.81% | -39.05% |